[Sinovac Reports Unaudited Third Quarter 2016 Financial Results BEIJING, Nov. 28, 2016 /PRNewswire/ -- Sinovac Biotech Ltd. (NASDAQ: SVA), a leading provider of biopharmaceutical products in China, announced today its unaudited third quarter ended September 30, 2016. Mr. Weidong Yin, Chairman, Presid]
[Sinovac Responds to Recent Report Sinovac Biotech Ltd. (NASDAQ: SVA), a leading provider of biopharmaceutical products in China BEIJING, China, December 23, 2016 -- Sinovac’s Audit Committee has authorized the commencement of an internal investigation into the allegations made in the report. The Aud]
[Sinovac Responds to Recent Report Sinovac Biotech Ltd. (NASDAQ: SVA), a leading provider of biopharmaceutical products in China BEIJING, China, December 23, 2016 -- Sinovac’s Audit Committee has authorized the commencement of an internal investigation into the allegations made in the report. The Aud]
[Sinovac Announces Results of 2016 Annual General Meeting of Shareholders BEIJING, November 7, 2016 /PRNewswire/ -- Sinovac Biotech Ltd. (NASDAQ:SVA), a leading provider of biopharmaceutical products in China, today announced the results of the Company's 2016 Annual General Meeting of Shareholders he]
[Sinovac Announces Results of 2016 Annual General Meeting of Shareholders BEIJING, November 7, 2016 /PRNewswire/ -- Sinovac Biotech Ltd. (NASDAQ:SVA), a leading provider of biopharmaceutical products in China, today announced the results of the Company's 2016 Annual General Meeting of Shareholders he]
[Sinovac Product Pipeline News Sinovac Biotech Ltd. (NASDAQ: SVA), a leading provider of biopharmaceutical products in China BEIJING, China, October 19, 2016 -- Sabin-inactivated polio vaccine (sIPV) Varicella vaccine Mr. Weidong Yin, Chairman, President and CEO of Sinovac commented, “We are pleased ]
[Sinovac Product Pipeline News Sinovac Biotech Ltd. (NASDAQ: SVA), a leading provider of biopharmaceutical products in China BEIJING, China, October 19, 2016 -- Sabin-inactivated polio vaccine (sIPV) Varicella vaccine Mr. Weidong Yin, Chairman, President and CEO of Sinovac commented, “We are pleased ]
[Sinovac Schedules 2016 Annual Meeting of Shareholders BEIJING , Sept. 30, 2016 /PRNewswire/ -- Sinovac Biotech Ltd. (NASDAQ: SVA), a leading provider of biopharmaceutical products in China, announced today that it will hold its 2016 Annual Meeting of Shareholders on Monday, November 7, 2016 at 9:00 ]
[Sinovac Schedules 2016 Annual Meeting of Shareholders BEIJING , Sept. 30, 2016 /PRNewswire/ -- Sinovac Biotech Ltd. (NASDAQ: SVA), a leading provider of biopharmaceutical products in China, announced today that it will hold its 2016 Annual Meeting of Shareholders on Monday, November 7, 2016 at 9:00 ]
[Sinovac Reports Unaudited Second Quarter 2016 Financial Results BEIJING, August 23, 2016 /PRNewswire/ -- Sinovac Biotech Ltd. (NASDAQ: SVA), a leading provider of biopharmaceutical products in China, announced today its unaudited second quarter ended June 30, 2016. Mr. Weidong Yin, Chairman, President and CEO of the Sinovac, commented, “As forecasted on our first quarter earnings call, we experienced a continued] []
